¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"average length of life"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® half-life ÇÑ±Û ¹Ý°¨±â
¼³¸í   
  ¾î¶² ¹°ÁúÀÌ ¿ÜºÎÀû ¿äÀÎ, ¶Ç´Â ³»ºÎÀû ¿äÀο¡ ÀÇÇØ¼­ ºÐÇØµÉ °æ¿ì¿¡ ±× ¹°ÁúÀÇ ¿ø·¡ÀÇ ¾ç¿¡¼­ ¹ÝÀÌ µÇ´Â µ¥ °É¸®´Â ½Ã°£.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average life expectancy
    Æò±Õ¿©¸í
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    1. Æò±Õ¿ë·® 2. Æò±Õ¼±·®
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • crown-heel length
    ¸Ó¸®¹ß²ÞÄ¡±æÀÌ, Á¤Á¾Àå
  • crown-rump length
    ¸Ó¸®¾ûµ¢±æÀÌ, Á¤µÐÀå
  • focal length
    ÃÊÁ¡°Å¸®, ÃÊÁ¡±æÀÌ
  • force velocity length relation
    Èû¼Óµµ±æÀ̰ü°è
  • length
    ±æÀÌ
  • length bias
    ±â°£Â÷À̹ÙÀ̾
  • length-height index
    ¸Ó¸®³ôÀ̱æÀÌÁö¼ö
  • quarter wave length matching
    »çºÐÇÒÆÄÁ¶È­
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • length
    ±æÀÌ
  • life style disease
    »ýȰ½À°üº´
  • half-life
    ¹Ý°¨±â
  • life
    »ýȰ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average life expectancy
    Æò±Õ±â´ë¿©¸í
  • average
    Æò±Õ
  • average deviation
    Æò±ÕÆíÂ÷
  • average dose
    Æò±Õ¿ë·®, Æò±Õ¼±·®
  • average movement articulator
    º¸Åë¿îµ¿±³ÇÕ±â
  • moving average
    À̵¿Æò±Õ
  • moving average method
    À̵¿Æò±Õ¹ý
  • length bias
    ±â°£Â÷À̹ÙÀ̾
  • crown-heel length
    ¸Ó¸®¹ß²ÞÄ¡±æÀÌ
  • crown-rump length
    ¸Ó¸®¾ûµ¢±æÀÌ
  • tension length curve
    Àå·Â±æÀ̰
  • tension length diagram curve
    Àå·Â±æÀ̵µÇ¥°î¼±
  • length tension diagram
    ±æÀÌÀå·Â±×¸²Ç¥
  • tension length diagram
    Àå·Â±æÀ̵µÇ¥
  • focal length
    ÃÊÁ¡°Å¸®, ÃÊÁ¡±æÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Length constant
    ±æÀÌÁö¼ö(¡­ò¦â¦)
  • Length/tension curve
    ±æÀÌ/Àå·Â(íåÕô) °î¼±(ÍØàÊ)
  • arm length
    »óÁö Àå(ß¾ò¶íþ), »óÁö ±æÀÌ, ÆÈ ±æÀÌ.
  • functional profile length
    ±â´ÉÀû(¿äµµ)Ãø¸é?±æÀÌ
  • gap length
    Æ´ÀÇ ±æÀÌ.
  • height length index
    ¼öÁ÷Áö¼ö(á÷òÁò¦â¦).
  • initial length
    ¿ø·¡±æÀÌ ¡ì±Ù(ÐÉ)ÀÇ¡í.
  • quarter wave length matching
    4 ºÐÇÒÆÄ Á¶È­
  • quarter-wave length matching
    4-ºÐÇÒÆÄ Á¶È­ (ÞÌ-ÝÂùÜ÷î ðàûú)
  • abridged life table
    °£ÀÌ»ý¸íÇ¥(˧ËöË×ËḬ̂).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • advanced trauma life support
    »ó±Þ ¿Ü»ó¼Ò»ý¼ú
  • aerospace life support system
    (Ç×°ø)¿ìÁÖ¿ë »ý¸íÀ¯Áö½Ã½ºÅÛ.
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • half-life
    ¹Ý°¨±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average length of life
    Æò±Õ¼ö¸í(̰˻ËÛËÎ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average length of stay
    Æò±Õ Àç¿øÀϼö
  • average expectation of life
    Æò±Õ¿©¸í(̰˻ËçËÎ).
  • average
    Æò±Õ(ÀÇ).
  • average count
    Æò±Õ¹ø¼ö(ÊÙËÑËà).
  • average deviation
    Æò±ÕÆíÂ÷(̰˻̰̤).
  • average dose
    Æò±Õ¿ë·®, Æò±ÕÁ¶»ç·®.
  • average molecular weight
    Æò±ÕºÐÀÚ·®.
  • average movement articulator
    º¸Åë ¿îµ¿ ±³ÇÕ±â.
  • average path
    Æò±ÕµµÁ¤(¡­Ô³ïï).
  • average value
    Æò±ÕÄ¡.
  • law of average
    Æò±Õ¹ýÄ¢(̰˻ËÑ̬).
  • moving average
    À̵¿Æò±Õ(ËöËÄ̰˻).
  • moving average method
    À̵¿Æò±Õ¹ý.
  • number of signal average (NSA)
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • time weighted average concentration
    ½Ã°£°¡Á߯ò±Õ³óµµ.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life cycle
    »ýȰ»ç
  • sylvatic life cycle
    ¹Ð¸²»ýȰȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • biological half-life
    »ý¹°ÇÐÀû ¹Ý°¨±â(ßæÚªùÊîÜÚâÊõÑ¢)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • half-life
    ¹Ý°¨±â(ÚâÊõÑ¢)
  • life cycle
    "»ýȰ»ç(ßæüÀÞÈ),»ýȰÁÖ±â(ßæüÀñÎÑ¢)"
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â(Úª×âîÜÚâÊõÑ¢)
  • radioactive half-life
    ¹æ»ç¼º ¹Ý°¨±â(Û¯ÞÒàõÚâÊõÑ¢)
  • bond length
    °áÇÕ(Ì¿ùê)±æÀÌ
  • chain length
    »ç½½ ±æÀÌ
  • contour length
    ½ÅÀå(ãßíþ)±æÀÌ
  • equivalent chain length
    µî(Ôõ)»ç½½ ±æÀÌ
  • fragment length mapping
    Á¶°¢ ±æÀÌ ÀÛµµ(íÂÓñ)
  • Kuhn statistical length
    Äï Åë°èÀû(÷ÖͪîÜ)±æÀÌ
  • minimal stable length
    ÃÖ¼Ò¾ÈÁ¤(õÌá³äÌïÒ) ±æÀÌ
  • restriction fragment length polymorphism
    Á¦ÇÑ Á¶°¢±æÀÌ ´ÙÇü¼º(Òýúþàõ)
  • triple-chain length
    »ï(ß²)»ç½½ ±æÀÌ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • average
    Æò±ÕÀÇ
  • number of signal average [=NSA]
    ½ÅÈ£Æò±Õȸ¼ö
  • crown rump length
    µÎÁ¤µÐºÎ±æÀÌ
  • echo train length
    ¿¡ÄÚ¿­±æÀÌ
  • focal length
    ÃÊÁ¡±æÀÌ
  • quarter wave length matching
    4ºÐÇÒÆÄÁ¶È­
  • spatial pulse length
    °ø°£ÆÞ½º±æÀÌ
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • effective half life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • half-life; half-time
    ¹Ý°¨±â
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
  • life threatening
    »ý¸íÀ» À§ÇùÇÏ´Â
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FL fatty liver; feline leukemia; femur length; fibers of Luschka; fibroblast-like; filtration leukapher...
CR Length Crown to Rump Length
CL capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ...
ALOS average length of stay
AER abduction/external rotation; acoustic evoked response; acute exertional rhabdomyolysis; agranular en...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALOS Average length of stay
AAPCC Adjusted Average Per Capita Cost
ARIMA Auto Regressive Integrated Moving Average
ARMA AutoRegressive Moving Average
ADFI Average daily feed intake
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average length of life
    Æò±Õ ¼ö¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average
    Æò±Õ, Æò±ÕÀÇ
  • average count
    Æò±Õ ¹ø¼ö
  • average dose
    Æò±Õ ¿ë·®, Æò±Õ Á¶»ç·®
  • average maintenance dose
    µð±âÅ»¸®½º Æò±Õ À¯Áö·®
  • average molecular weight
    Æò±Õ ºÐÀÚ·®
  • average value
    Æò±ÕÄ¡
  • number of signal average
    ½ÅÈ£ Æò±Õ ȸ¼ö
  • time weighted average concentration
    ½Ã°£ °¡Áß Æò±Õ ³óµµ
  • crown rump length
    µÎÁ¤ µÐºÎ ±æÀÌ
  • dental length
    Ä¡¿­ÀÇ ±æÀÌ
  • echo train length
    ¿¡ÄÚ ¿­ ±æÀÌ
  • focal length
    ÃÊÁ¡ °Å¸®
    Áý±¤ ·»Áî·ÎºÎÅÍ ÃÖ´ë ÃÊÁ¡ À§Ä¡±îÁöÀÇ °Å¸®.
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • length of dental arch
    Ä¡¿­±Ã ±æÀÌ
  • length of tooth
    Ä¡¾ÆÀå
    Ä¡¾ÆÀÇ ±æÀÌ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
average <statistics> A value that represents the sum of values divided by the number of values in the set. It represents or summarises the relevant features of a set of values.
Origin: M.E. Averays, loss from damage to ship or cargo, fr. It. Avaris, fr. Ar. 'awariya, damaged goods, + damage
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
average megawatt <physics> One megawatt of capacity produced continuously over a period of one year. 1 MWa = 1 MW x 8760 hours/year = 8,760 Mwh = 8,760,000 kWh.
Acronym: MWa
(05 Dec 1998)
average pulse magnitude <physics> The amplitude of pulse averaged throughout its duration; identical with peak amplitude for a square wave or pulse without droop.
(05 Mar 2000)
law of average localization Visceral pain is most accurately localised in the least mobile viscera and least accurately in the most mobile.
(05 Mar 2000)
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
arch length The amount of space required for the permanent teeth as measured from the mesial aspect of the first molar on one side to the mesial aspect of the first molar on the opposite side, as measured through the contact points along an imaginary line of the dental arch.
(05 Mar 2000)
arch length deficiency The difference between the available circumference of the dental arch and that required to accommodate the succedaneous teeth in proper alignment.
(05 Mar 2000)
available arch length <dentistry> The amount of space available for the permanent teeth around the dental arch from the first permanent molar on the left to the first permanent molar on the right.
(05 Mar 2000)
back focal length <microscopy> As measured on the principal axis, from the second lens vertex to the back focal point of the lens. It is not the equivalent of the focal length.
(05 Aug 1998)
bellows length <microscopy> The distance from the eye point to the image plane in a photomicrographic apparatus.
(05 Aug 1998)
bond length This is the distance between the nuclei of two atoms which have formed bonds with each other.
(09 Oct 1997)
passive length-tension curve The relationship between passive tension and preload (rest length) for a muscle at rest.
(05 Mar 2000)
required arch length The sum of the mesiodistal widths of the permanent teeth from first permanent molar to first permanent molar.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • at length
    µåµð¾î, »ó¼¼È÷, ÃæºÐÈ÷
  • length
    ±æÀÌ
  • cable('s) length
    ¿¬(100-120±æ(fathoms);¾à 185m)
  • field length
    ÀÌÂø·ú ȰÁÖ °Å¸®
  • focal length
    ÃÊÁ¡°Å¸®
  • graduated length method
    Á¡Â÷Àû ±æÀÌ º¯°æ¹ý(±â¼úÀÇ Çâ»ó¿¡ µû¶ó ½ºÅ°¸¦ ±ä °ÍÀ¸·Î Á¡Â÷ ¹Ù²Ù¾î °¡´Â ½ºÅ° Áöµµ¹ý)
  • length
    ±æÀÌ;±âÀå;¼¼·Î;±â°£;1¸¶½Å;at full ~ ±æ°Ô;at ~ µåµð¾î;go all ~s;or go to grent(any)~ ¾î¶² ÀÏÀÌ¶óµµ ÇØÄ¡¿ì´Ù
  • whole-length
    ÀüÀå(Àü½Å)ÀÇ
  • average
    Æò±Õ,Æò±ÕÀÇ,º¸ÅëÀÇ,Æò±ÕÇÏ´Ù
  • DowJones average
    (Áõ±Ç)´Ù¿ì Á¸½º Æò±Õ(ÁÖ°¡)
  • DowJones industrial average
    ´Ù¿ì Á¸½º °ø¾÷ÁÖ(ÁÖ) Æò±Õ
  • average
    Æò±ÕÀÇ;Ç¥ÁØÀÇ;º¸ÅëÀÇ;ÇØ¼Õ-Æò±ÕÇÏ´Ù;Æò±Õ ...ÀÌ µÇ´Ù;(Áõ±Ç µûÀ§¸¦ ¸Å¸ÅÇÏ¿©)Æò±Õ°ªÀ» ³»¸®´Ù
  • earned run average
    (¾ß±¸)(Åõ¼öÀÇ)¹æ¾îÀ²
  • fielding average
    ¼öºñÀ²
  • general average
    °øµ¿ ÇØ¼Õ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á